Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16540568rdf:typepubmed:Citationlld:pubmed
pubmed-article:16540568lifeskim:mentionsumls-concept:C0013384lld:lifeskim
pubmed-article:16540568lifeskim:mentionsumls-concept:C1704675lld:lifeskim
pubmed-article:16540568lifeskim:mentionsumls-concept:C1415300lld:lifeskim
pubmed-article:16540568lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:16540568lifeskim:mentionsumls-concept:C1511545lld:lifeskim
pubmed-article:16540568pubmed:issue11lld:pubmed
pubmed-article:16540568pubmed:dateCreated2006-3-16lld:pubmed
pubmed-article:16540568pubmed:abstractTextAbnormal function of NMDA receptor has been suggested to be correlated with the pathogenesis of Parkinson's disease (PD) as well as with the development of l-3,4-dihydroxyphenylalanine (L-DOPA)-induced dyskinesia. Here we show that NMDA receptor NR2 subunits display specific alterations of their subcellular distribution in striata from unilateral 6-hydroxydopamine-lesioned, L-DOPA-treated dyskinetic, and L-DOPA-treated nondyskinetic rats. Dyskinetic animals have significantly higher levels of NR2A subunit in the postsynaptic compartment than all other experimental groups, whereas NR2B subunit shows a significant reduction in both dopamine-denervated and dyskinetic rats. These events are paralleled by profound modifications of NMDA receptor NR2B subunit association with interacting elements, i.e., members of the membrane-associated guanylate kinase (MAGUK) protein family postsynaptic density-95, synapse-associated protein-97 and synapse-associated protein-102. Treatment of nondyskinetic animals with a synthetic peptide (TAT2B) able to affect NR2B binding to MAGUK proteins as well as synaptic localization of this subunit in nondyskinetic rats was sufficient to induce a shift of treated rats toward a dyskinetic motor behavior. These data indicate abnormal NR2B redistribution between synaptic and extrasynaptic membranes as an important molecular disturbance of the glutamatergic synapse involved in L-DOPA-induced dyskinesia.lld:pubmed
pubmed-article:16540568pubmed:languageenglld:pubmed
pubmed-article:16540568pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16540568pubmed:citationSubsetIMlld:pubmed
pubmed-article:16540568pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16540568pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16540568pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16540568pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16540568pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16540568pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16540568pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16540568pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16540568pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16540568pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16540568pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16540568pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16540568pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16540568pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16540568pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16540568pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16540568pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16540568pubmed:statusMEDLINElld:pubmed
pubmed-article:16540568pubmed:monthMarlld:pubmed
pubmed-article:16540568pubmed:issn1529-2401lld:pubmed
pubmed-article:16540568pubmed:authorpubmed-author:CattabeniFlam...lld:pubmed
pubmed-article:16540568pubmed:authorpubmed-author:Di...lld:pubmed
pubmed-article:16540568pubmed:authorpubmed-author:PicconiBarbar...lld:pubmed
pubmed-article:16540568pubmed:authorpubmed-author:BernardiGiorg...lld:pubmed
pubmed-article:16540568pubmed:authorpubmed-author:CalabresiPaol...lld:pubmed
pubmed-article:16540568pubmed:authorpubmed-author:GardoniFabriz...lld:pubmed
pubmed-article:16540568pubmed:authorpubmed-author:GhiglieriVero...lld:pubmed
pubmed-article:16540568pubmed:authorpubmed-author:PolliFederica...lld:pubmed
pubmed-article:16540568pubmed:authorpubmed-author:BagettaVincen...lld:pubmed
pubmed-article:16540568pubmed:issnTypeElectroniclld:pubmed
pubmed-article:16540568pubmed:day15lld:pubmed
pubmed-article:16540568pubmed:volume26lld:pubmed
pubmed-article:16540568pubmed:ownerNLMlld:pubmed
pubmed-article:16540568pubmed:authorsCompleteYlld:pubmed
pubmed-article:16540568pubmed:pagination2914-22lld:pubmed
pubmed-article:16540568pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:16540568pubmed:meshHeadingpubmed-meshheading:16540568...lld:pubmed
pubmed-article:16540568pubmed:meshHeadingpubmed-meshheading:16540568...lld:pubmed
pubmed-article:16540568pubmed:meshHeadingpubmed-meshheading:16540568...lld:pubmed
pubmed-article:16540568pubmed:meshHeadingpubmed-meshheading:16540568...lld:pubmed
pubmed-article:16540568pubmed:meshHeadingpubmed-meshheading:16540568...lld:pubmed
pubmed-article:16540568pubmed:meshHeadingpubmed-meshheading:16540568...lld:pubmed
pubmed-article:16540568pubmed:meshHeadingpubmed-meshheading:16540568...lld:pubmed
pubmed-article:16540568pubmed:meshHeadingpubmed-meshheading:16540568...lld:pubmed
pubmed-article:16540568pubmed:meshHeadingpubmed-meshheading:16540568...lld:pubmed
pubmed-article:16540568pubmed:meshHeadingpubmed-meshheading:16540568...lld:pubmed
pubmed-article:16540568pubmed:meshHeadingpubmed-meshheading:16540568...lld:pubmed
pubmed-article:16540568pubmed:meshHeadingpubmed-meshheading:16540568...lld:pubmed
pubmed-article:16540568pubmed:meshHeadingpubmed-meshheading:16540568...lld:pubmed
pubmed-article:16540568pubmed:meshHeadingpubmed-meshheading:16540568...lld:pubmed
pubmed-article:16540568pubmed:meshHeadingpubmed-meshheading:16540568...lld:pubmed
pubmed-article:16540568pubmed:meshHeadingpubmed-meshheading:16540568...lld:pubmed
pubmed-article:16540568pubmed:meshHeadingpubmed-meshheading:16540568...lld:pubmed
pubmed-article:16540568pubmed:meshHeadingpubmed-meshheading:16540568...lld:pubmed
pubmed-article:16540568pubmed:meshHeadingpubmed-meshheading:16540568...lld:pubmed
pubmed-article:16540568pubmed:meshHeadingpubmed-meshheading:16540568...lld:pubmed
pubmed-article:16540568pubmed:meshHeadingpubmed-meshheading:16540568...lld:pubmed
pubmed-article:16540568pubmed:meshHeadingpubmed-meshheading:16540568...lld:pubmed
pubmed-article:16540568pubmed:meshHeadingpubmed-meshheading:16540568...lld:pubmed
pubmed-article:16540568pubmed:meshHeadingpubmed-meshheading:16540568...lld:pubmed
pubmed-article:16540568pubmed:meshHeadingpubmed-meshheading:16540568...lld:pubmed
pubmed-article:16540568pubmed:meshHeadingpubmed-meshheading:16540568...lld:pubmed
pubmed-article:16540568pubmed:meshHeadingpubmed-meshheading:16540568...lld:pubmed
pubmed-article:16540568pubmed:meshHeadingpubmed-meshheading:16540568...lld:pubmed
pubmed-article:16540568pubmed:year2006lld:pubmed
pubmed-article:16540568pubmed:articleTitleA critical interaction between NR2B and MAGUK in L-DOPA induced dyskinesia.lld:pubmed
pubmed-article:16540568pubmed:affiliationCenter of Excellence on Neurodegenerative Diseases, Department of Pharmacological Sciences, University of Milan, 20133 Milan, Italy.lld:pubmed
pubmed-article:16540568pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16540568pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:24409entrezgene:pubmedpubmed-article:16540568lld:entrezgene
entrez-gene:24410entrezgene:pubmedpubmed-article:16540568lld:entrezgene
entrez-gene:25252entrezgene:pubmedpubmed-article:16540568lld:entrezgene
entrez-gene:29495entrezgene:pubmedpubmed-article:16540568lld:entrezgene
entrez-gene:58948entrezgene:pubmedpubmed-article:16540568lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:16540568lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:16540568lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:16540568lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:16540568lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:16540568lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16540568lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16540568lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16540568lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16540568lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16540568lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16540568lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16540568lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16540568lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16540568lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16540568lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16540568lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16540568lld:pubmed
More...